← Back to Search

Tailored letter for Diabetes

N/A
Waitlist Available
Led By John R Guzek, MD
Research Sponsored by Scranton-Temple Residency Program
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

The purpose of this study is to determine if tailored letters sent to diabetic patients will improve care of diabetes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Tailored letterExperimental Treatment1 Intervention
Patients in the tailored letter group received by mail a tailored letter detailing their diabetes measures, together with enclosed orders for lab tests when due, and reminder of or scheduling for an office appointment.
Group II: Usual CareActive Control1 Intervention
Patients in the usual care group were part of a practice wide quality improvement process.

Find a Location

Who is running the clinical trial?

Scranton-Temple Residency ProgramLead Sponsor
1 Previous Clinical Trials
100 Total Patients Enrolled
John R Guzek, MDPrincipal InvestigatorScranton-Temple Residency Program
1 Previous Clinical Trials
100 Total Patients Enrolled
~28 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top